Davis; Faith B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Davis; Faith B..The latest application filed is for "nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof".

Company Profile

0.17.13

Davis; Faith B. - West Sand Lake NY US
Davis; Faith B. - Latham NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thyroid hormone analogs and methods of use Grant 9,980,933 - Mousa , et al. May 29, 2	2018-05-29
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof Grant 9,750,709 - Mousa , et al. September 5, 2	2017-09-05
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof Grant 9,579,300 - Mousa , et al. February 28, 2	2017-02-28
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof Grant 9,220,788 - Davis , et al. December 29, 2	2015-12-29
Thyroid hormone analogs and methods of use Grant 9,198,887 - Mousa , et al. December 1, 2	2015-12-01
Combination treatment of cancer with cetuximab and tetrac Grant 9,180,107 - Lin , et al. November 10, 2	2015-11-10
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations Thereof App 20140314665 - Mousa; Shaker A. ; et al.	2014-10-23
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations Thereof App 20140199376 - Mousa; Shaker A. ; et al.	2014-07-17
Thyroid Hormone Analogs And Methods Of Use App 20140072635 - Mousa; Shaker A. ; et al.	2014-03-13
Thyroid Hormone Analogs And Methods Of Use App 20140072646 - Mousa; Shaker A. ; et al.	2014-03-13
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof Grant 8,668,926 - Mousa , et al. March 11, 2	2014-03-11
Thyroid hormone analogs and methods of use Grant 8,518,451 - Mousa , et al. August 27, 2	2013-08-27
Thyroid hormone analogs and methods of use Grant 8,071,134 - Mousa , et al. December 6, 2	2011-12-06
Inhibitors of PGHS-2Transactivator activity Grant 7,927,799 - Cao , et al. April 19, 2	2011-04-19
Nanoparticle And Polymer Formulations For Thyroid Hormone Analogs, Antagonists, And Formulations And Uses Thereof App 20110052715 - Davis; Paul J. ; et al.	2011-03-03
Combination Treatment of Cancer With Cetuximab and Tetrac App 20100255108 - Lin; Hung-Yun ; et al.	2010-10-07
Thyroid hormone analogs and methods of use Grant 7,785,632 - Mousa , et al. August 31, 2	2010-08-31
Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use App 20100159021 - Davis; Paul ; et al.	2010-06-24
Thyroid Hormone Analogs and Methods of Use App 20100112079 - Mousa; Shaker A. ; et al.	2010-05-06
Inhibitors of PGHS-2Transactivator Activity App 20090298058 - Cao; Huiyu ; et al.	2009-12-03
Thyroid Hormone Analogs and Methods of Use App 20080124280 - Mousa; Shaker A. ; et al.	2008-05-29
Thyroid hormone analogs and methods of use App 20050124862 - Mousa, Shaker A. ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.